| Date Filed | Type | Description |
| 08/07/2023 |
4
| BARER SOL J (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Exercised 28,162 options to buy
@ $0 |
|
| 07/07/2023 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 44,983 options to buy
@ $0.29, valued at
$13k
|
|
| 03/31/2023 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 400,000 shares
@ $0.4103, valued at
$164.1k
|
|
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 61,678 options to buy
@ $1.82, valued at
$112.3k
|
|
| 06/02/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 20,720 shares
@ $2.2249, valued at
$46.1k
Bought 40,000 shares
@ $2.354, valued at
$94.2k
Bought 39,280 shares
@ $2.1867, valued at
$85.9k
|
|
| 05/18/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on CONTRAFECT Corp|
Txns:
| Granted 42,000 options to buy
@ $3.35, valued at
$140.7k
|
|
| 03/24/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 10,000 shares
@ $2.6653, valued at
$26.7k
|
|
| 03/23/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 30,000 shares
@ $2.41, valued at
$72.3k
|
|
| 03/22/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 30,000 shares
@ $2.136, valued at
$64.1k
|
|
| 03/21/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 30,000 shares
@ $2.107, valued at
$63.2k
|
|
| 02/11/2022 |
SC 13G
| BARER SOL J reports a 7% stake in NEXIMMUNE, INC. |
| 12/22/2021 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Exercised 50,000 options to buy
@ $5.17, valued at
$258.5k
|
|
| 06/17/2021 |
4
| BARER SOL J (Director) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.56, valued at
$142.4k
|
|
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| BARER SOL J (Director) has filed a Form 4 on CONTRAFECT Corp|
Txns:
| Granted 25,000 options to buy
@ $3.86, valued at
$96.5k
|
|
| 02/19/2021 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Converted 800,182 shares
@ $0
Converted 894,036 shares
@ $0
Converted 164,408 shares
@ $0
Converted 82,204 shares
@ $0
Converted 337,365 shares
@ $0
Bought 60,000 shares
@ $17, valued at
$1M
Converted 217,570 shares
@ $0
Converted 800,182 preferred shares
@ $0
Converted 894,036 preferred shares
@ $0
Converted 164,408 options to buy
@ $0
Converted 82,204 options to buy
@ $0 |
|
| 02/16/2021 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 19,113 options to buy
@ $17, valued at
$324.9k
|
|
| 02/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| BARER SOL J (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Exercised 31,388 options to buy
@ $0 |
|
| 06/11/2020 |
4
| BARER SOL J (Director) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Granted 22,565 options to buy
@ $0 |
|
| 05/18/2020 |
4
| BARER SOL J (Director) has filed a Form 4 on CONTRAFECT Corp |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| BARER SOL J (Director) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 500,000 options to buy
@ $3.98, valued at
$2M
|
|
| 02/05/2020 |
3
| BARER SOL J (Director) has filed a Form 3 on Cerecor Inc. |
| 02/05/2020 |
4
| BARER SOL J (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 200,000 options to buy
@ $5.22, valued at
$1M
Disposed/sold 200,000 options to buy
@ $5.22, valued at
$1M
Disposed/sold 15,000 options to buy
@ $7.25, valued at
$108.8k
Disposed/sold 15,000 options to buy
@ $6.5, valued at
$97.5k
Disposed/sold 80,000 options to buy
@ $7.01, valued at
$560.8k
Disposed/sold 80,000 options to buy
@ $4.83, valued at
$386.4k
Disposed/sold 80,000 options to buy
@ $1.32, valued at
$105.6k
Disposed/sold 100,000 options to buy
@ $1.55, valued at
$155k
Disposed/sold 74,912 warrants
@ $2.84, valued at
$212.8k
|
|
| 12/09/2019 |
4
| BARER SOL J (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Gifted 153,846 shares
@ $0
Gifted 153,846 shares
@ $0
Gifted 365,854 shares
@ $0
Gifted 365,854 shares
@ $0
Disposed of 2,551,020 shares
@ $0
Acquired 2,551,020 shares
@ $0
Sold 4,098,752 shares
@ $0.134, valued at
$549.2k
|
|
|